人群筛查2型糖尿病和心血管危险因素对死亡率和心血管事件的影响:一项针对1,912,392名丹麦成年人的对照试验
该研究在丹麦40-69岁无已知糖尿病的人群中评估基于人群的2型糖尿病和心血管危险因素筛查对死亡率和心血管事件的影响,纳入1,912,392人。筛查组27,177人(18%)参加评估,中位随访9.5年。筛查组与不筛查组的死亡率(HR 0.99 [95% CI 0.96, 1.02], p=0.66)和心血管事件(HR 0.99 [0.96, 1.02], p=0.49)均无显著差异,筛查未显著降低死亡率和心血管事件。
要点
- 筛查组27,177人(18%)参加评估,其中1,533人诊断糖尿病。
- 中位随访9.5年,筛查组死亡11,826例 vs 不筛查组141,719例,HR 0.99(95% CI 0.96, 1.02),p=0.66。
- 筛查组心血管事件17,941例 vs 不筛查组208,476例,HR 0.99(0.96, 1.02),p=0.49,无显著差异。
核心结论
- 在丹麦中年成年人中,基于人群的2型糖尿病和心血管危险因素阶梯式筛查未显著降低死亡率和心血管事件。
研究设计与样本
- 基于登记的非随机对照试验,纳入40-69岁无已知糖尿病且在全科诊所注册的丹麦人群,共1,912,392人。
- 2001-2006年,153,107人(181家参与ADDITION-Denmark研究诊所)收到糖尿病风险评分问卷,中高危者受邀至全科医生处评估(筛查组);其余1,759,285人为回顾性构建的不筛查对照组。
- 分析按意向筛查原则进行。
主要发现
- 筛查组27,177人(18%)参加评估,其中1,533人诊断糖尿病。
- 中位随访9.5年,筛查组死亡11,826例 vs 不筛查组141,719例,HR 0.99(95% CI 0.96, 1.02),p=0.66,未达统计学显著。
- 筛查组心血管事件17,941例 vs 不筛查组208,476例,HR 0.99(95% CI 0.96, 1.02),p=0.49,未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Health check programmes for chronic disease have been introduced in a number of countries. However, there are few trials assessing the benefits and harms of these screening programmes at the population level. In a post hoc analysis, we evaluated the effect of population-based screening for type 2 diabetes and cardiovascular risk factors on mortality rates and cardiovascular events. METHODS: This register-based, non-randomised, controlled trial included men and women aged 40-69 years without known diabetes who were registered with a general practice in Denmark (n = 1,912,392). Between 2001 and 2006, 153,107 individuals registered with 181 practices participating in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Denmark study were sent a diabetes risk score questionnaire. Individuals at moderate-to-high risk were invited to visit their GP for assessment of diabetes status and cardiovascular risk (screening group). The 1,759,285 individuals registered with all other general practices in Denmark constituted the retrospectively constructed no-screening (control) group. Outcomes were mortality rate and cardiovascular events (cardiovascular disease death, non-fatal ischaemic heart disease or stroke). The analysis was performed according to the intention-to-screen principle. RESULTS: Among the screening group, 27,177 (18%) individuals attended for assessment of diabetes status and cardiovascular risk. Of these, 1,533 were diagnosed with diabetes. During a median follow-up of 9.5 years, there were 11,826 deaths in the screening group and 141,719 in the no-screening group (HR 0.99 [95% CI 0.96, 1.02], p = 0.66). There were 17,941 cardiovascular events in the screening group and 208,476 in the no-screening group (HR 0.99 [0.96, 1.02], p = 0.49). CONCLUSIONS/INTERPRETATION: A population-based stepwise screening programme for type 2 diabetes and cardiovascular risk factors among all middle-aged adults in Denmark was not associated with a reduction in rate of mortality or cardiovascular events between 2001 and 2012.
引用
- Simmons RK, Griffin SJ, Witte DR, et al. Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults. Diabetologia. 2017. PMID: 28831535. doi:10.1007/s00125-017-4323-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。